The results of the COPE Clinical Trial were presented at the ATC last month. Prof Jochmans (Leuven Hospital) gave an excellent lecture and the abstract can be found on the ATC website. The Kidney Assist-transport is the only system used in this trial. Industry unique aspect of the Kidney Assist-transport is the oxygenation through an oxygenator which allows for reaching fast (approx. 4 minutes) and high (90 kPa) oxygen pressures.
Outcome: improved kidney function and less graft loss at 1 year followup.